{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:23Z","timestamp":1792788143396,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.msard.2026.107982","type":"journal-article","created":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:12:10Z","timestamp":1791756730000},"page":"107982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Beyond physical disability: the case for systematic mental health screening in the care of NMOSD and MOGAD in Latin America"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9027-4896","authenticated-orcid":false,"given":"Stefany","family":"Espinoza-Ram\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107982_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106244","article-title":"Recommendations on NMOSD treatment in Latin America: utilizing consensus-based RAND\/UCLA methodology","volume":"94","author":"Alonso","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107982_bib0002","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s10072-023-06617-y","article-title":"Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis","volume":"44","author":"Bagherieh","year":"2023","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2026.107982_bib0003","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107982_bib0004","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.msard.2018.04.009","article-title":"Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: the first report from Iran","volume":"22","author":"Barzegar","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2026.107982_bib0005","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000580","article-title":"Neuromyelitis optica spectrum disorder: patient experience and quality of life","volume":"6","author":"Beekman","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.msard.2026.107982_bib0006","doi-asserted-by":"crossref","first-page":"74","DOI":"10.31083\/j.jin2304074","article-title":"Neuromyelitis Optica spectrum disorder in Latin America: state-of-the-art and current challenges","volume":"23","author":"Carnero Contentti","year":"2024","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.msard.2026.107982_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103647","article-title":"Health-related quality of life in neuromyelitis optica spectrum disorder patients in an Argentinean cohort","volume":"59","author":"Carnero Contentti","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107982_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102428","article-title":"Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice","volume":"45","author":"Carnero Contentti","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2026.107982_bib0009","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000286","article-title":"Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder","volume":"3","author":"Chavarro","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107982_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1587804","article-title":"Neuropsychiatric disorders among Ecuadorian patients with multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"16","author":"Correa-D\u00edaz","year":"2025","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2026.107982_bib0011","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00006842-200107000-00021","article-title":"Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital spanish inpatients","volume":"63","author":"Diez-Quevedo","year":"2001","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.msard.2026.107982_bib0012","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.msard.2017.11.002","article-title":"Psychiatric comorbidities and suicidality among patients with neuromyelitis optica spectrum disorders in Argentina","volume":"19","author":"Fern\u00e1ndez","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"11","key":"10.1016\/j.msard.2026.107982_bib0013","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1177\/13524585251349139","article-title":"Unemployment, work hour reduction, and income loss: an international, multicentered, cross-sectional study of neuromyelitis optica spectrum disorder","volume":"31","author":"Ham","year":"2025","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107982_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.843909","article-title":"Factors influencing social participation among persons with neuromyelitis optica spectrum disorders: a cross-sectional study","volume":"13","author":"Jia","year":"2022","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2026.107982_bib0015","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"issue":"11","key":"10.1016\/j.msard.2026.107982_bib0016","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2026.107982_bib0017","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s40120-022-00356-6","article-title":"Impact of neuromyelitis optica spectrum disorder on quality of life from the patients' perspective: an observational cross-sectional study","volume":"11","author":"Meca-Lallana","year":"2022","journal-title":"Neurol. Ther."},{"issue":"9","key":"10.1016\/j.msard.2026.107982_bib0018","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/jnnp-2025-338335","article-title":"Psychiatric comorbidities cluster early after onset in MOGAD: a cross-sectional comparative study with MS and NMOSD","volume":"97","author":"Niederschweiberer","year":"2026","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.msard.2026.107982_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197943","article-title":"Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: a systematic review","volume":"14","author":"Patrick","year":"2019","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.msard.2026.107982_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.17843\/rpmesp.2022.391.8620","article-title":"Psychometric properties of the GAD-7 to detect generalized anxiety in health professionals in Bolivia","volume":"39","author":"Porto","year":"2022","journal-title":"Rev. Peru Med. Exp. Salud. Public."},{"issue":"3","key":"10.1016\/j.msard.2026.107982_bib0021","article-title":"Quality of life is impaired in myelin oligodendrocyte glycoprotein antibody associated disease","volume":"10","author":"Said","year":"2024","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2026.107982_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1265170","article-title":"Association of aquaporin-4 antibody-seropositive optic neuritis with vision-related quality of life and depression","volume":"14","author":"Song","year":"2023","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2026.107982_bib0023","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.msard.2026.107982_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104485","article-title":"Barriers to access and unmet needs to neuromyelitis optica spectrum disorders care in an Argentinean cohort","volume":"70","author":"Tkachuk","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2026.107982_bib0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s40359-024-01688-8","article-title":"Psychometric properties of the GAD-7 (General Anxiety Disorder-7): a cross-sectional study of the Peruvian general population","volume":"12","author":"Villarreal-Zegarra","year":"2024","journal-title":"BMC. Psychol."},{"issue":"2","key":"10.1016\/j.msard.2026.107982_bib0026","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826010175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826010175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:01Z","timestamp":1792787281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826010175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":26,"alternative-id":["S2211034826010175"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107982","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond physical disability: the case for systematic mental health screening in the care of NMOSD and MOGAD in Latin America","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107982"}}